3 November 2021 - Let’s just kick this off by addressing the elephant in the room. Trikafta, the breakthrough treatment for cystic fibrosis is an expensive, but life changing drug.

PHARMAC, our drug-buying agency, have labelled it a “paradigm shift” and can probably negotiate a 50% reduction in price, but it will still need close to $60 million in additional government funding to treat 400 eligible New Zealanders every year.

Read Stuff article